Reaktion #619141

ord-3bc5b07f3235400ba1b4566e0f9bfc29

Reaktionsgleichung

C[C@H]1CC[C@H](N(C(=O)Nc2ncc(C=O)s2)C2CCCCCC2)CC1
trans-1-cycloheptyl-3-(5-formyl-thiazol-2-yl)-1-(4-methyl-cyclohexyl)-urea
COC(=O)CCS(=O)(=O)N1CC[NH2+]CC1.[Cl-]
4-(2-methoxycarbonyl-ethanesulfonyl)-piperazin-1-ium chloride
→
COC(=O)CCS(=O)(=O)N1CCN(Cc2cnc(NC(=O)N(C3CCCCCC3)[C@H]3CC[C@H](C)CC3)s2)CC1
Trans-3-(4-{2-[3-cycloheptyl-3-(4-methyl-cyclohexyl)-ureido]-thiazol-5-ylmethyl}-piperazine-1-sulfonyl)-propionic acid methyl ester

Edukte

C[C@H]1CC[C@H](N(C(=O)Nc2ncc(C=O)s2)C2CCCCCC2)CC1
trans-1-cycloheptyl-3-(5-formyl-thiazol-2-yl)-1-(4-methyl-cyclohexyl)-urea
COC(=O)CCS(=O)(=O)N1CC[NH2+]CC1.[Cl-]
4-(2-methoxycarbonyl-ethanesulfonyl)-piperazin-1-ium chloride

Reagenzien

Keine

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    SonstigePrepared in 65% (380 mg)
  2. 2
    Sonstigeyield

Vorschrift

Prepared in 65% (380 mg) yield as described in general procedure (B) from trans-1-cycloheptyl-3-(5-formyl-thiazol-2-yl)-1-(4-methyl-cyclohexyl)-urea (364 mg, 1.0 mmol) and 4-(2-methoxycarbonyl-ethanesulfonyl)-piperazin-1-ium chloride (273 mg, 1 mmol).

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: USRE045183E1uspto-grants-2014_10